Adolescent decision making about participation in a hypothetical HIV vaccine trial.

TitleAdolescent decision making about participation in a hypothetical HIV vaccine trial.
Publication TypePublication
Year of Publication2015
AuthorsAlexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD
Corporate AuthorsAdolescent Trials Network for HIV/AIDS Interventions
JournalVaccine
Volume33
Issue11
Pagination1331-7
Date Published2015 Mar 10
ISSN1873-2518
KeywordsAdolescent, Adult, AIDS Vaccines, Clinical Trials as Topic, Decision Making, Female, Health Knowledge, Attitudes, Practice, Humans, Informed Consent, Male, Motivation, Patient Participation, Research Subjects, Sexual Behavior, Young Adult
Abstract

<p><b>PURPOSE: </b>The purpose of this study was to examine the process of adolescent decision-making about participation in an HIV vaccine clinical trial, comparing it to adult models of informed consent with attention to developmental differences.</p><p><b>METHODS: </b>As part of a larger study of preventive misconception in adolescent HIV vaccine trials, we interviewed 33 male and female 16-19-year-olds who have sex with men. Participants underwent a simulated HIV vaccine trial consent process, and then completed a semistructured interview about their decision making process when deciding whether or not to enroll in and HIV vaccine trial. An ethnographic content analysis approach was utilized.</p><p><b>RESULTS: </b>Twelve concepts related to adolescents' decision-making about participation in an HIV vaccine trial were identified and mapped onto Appelbaum and Grisso's four components of decision making capacity including understanding of vaccines and how they work, the purpose of the study, trial procedures, and perceived trial risks and benefits, an appreciation of their own situation, the discussion and weighing of risks and benefits, discussing the need to consult with others about participation, motivations for participation, and their choice to participate.</p><p><b>CONCLUSION: </b>The results of this study suggest that most adolescents at high risk for HIV demonstrate the key abilities needed to make meaningful decisions about HIV vaccine clinical trial participation.</p>

DOI10.1016/j.vaccine.2015.01.049
Alternate JournalVaccine
PubMed ID25645175
PubMed Central IDPMC4379417
Grant ListU01 HD040533 / HD / NICHD NIH HHS / United States
U01 HD040474 / HD / NICHD NIH HHS / United States
K23 HD049444 / HD / NICHD NIH HHS / United States
5 U01 HD 40533 / HD / NICHD NIH HHS / United States
1 K23 HD 049444-01 / HD / NICHD NIH HHS / United States
P30 AI042853 / AI / NIAID NIH HHS / United States
5 U01 HD 40474 / HD / NICHD NIH HHS / United States